Efgartigimod PH20 SC
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Efgartigimod PH20 SC, covering 2025-10-23 to 2026-07-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. [Phase 2, Phase 3]